Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Film Coated Tablets 1 x 600 mg |
|
||
|
Film Coated Tablets 10 x 600 mg |
|
||
|
Film Coated Tablets 20 x 600 mg |
|
||
|
Film Coated Tablets 30 x 600 mg |
|
||
|
Film Coated Tablets 50 x 600 mg |
|
||
|
Film Coated Tablets 60 x 600 mg |
|
||
|
Film Coated Tablets 100 x 600 mg |
|
||
|
Film Coated Tablets 200 x 600 mg |
|
Related information
Dosage
The dosage and treatment regimen is depended on indication. linezolid dosage should be administered orally twice daily. Please refer to the license holder for further details.
Indications
Therapy is indicated only when an organism resistant to all other antibiotics is suspected.
This medicinal product is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as:
1) Pneumonia – community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (MDRSP).
2) Skin and soft tissue infections including diabetic foot infections.
3) Enterococcal infections.
Combination therapy may be indicated if a concomitant Gram-negative pathogen is documented or suspected.
Contra-Indications
Hypersensitivity to the active substance or to any of the excipients.
Breastfeeding.
Patients taking any medicinal product which inhibits monoamine oxidases A or B (e.g., phenelzine, isocarboxazid, selegiline, moclobemide) or within two weeks of taking any such medicinal product.
Special Precautions
Please refer to the license holder for further details.
Side Effects
Please refer to the license holder for further details.
Drug interactions
Please refer to the license holder for further details.
Pregnancy and Lactation
Please refer to the license holder for further details.
Overdose
Please refer to the license holder for further details.
